Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ZappRx

ZappRx
2012 FOUNDED
M&A STATUS
41-50 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Provider of a digital health platform intended to simplify the way specialty medications are managed. The company's platform automates the prescription management process, enabling patients, physicians and pharmacists to work together to improve patients' access to treatment, deliver medicine faster with fewer hassles and greater transparency.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Medical Records Systems
Other Healthcare Technology Systems
Primary Office
  • 100 Franklin Street
  • Boston, MA 02110
  • United States

+1 (855) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ZappRx’s full profile, request a free trial.

ZappRx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 13-Jun-2019 000.00 Completed Generating Revenue
8. Later Stage VC 000.00 Completed Generating Revenue
7. Corporate 17-Oct-2018 000.00 Completed Generating Revenue
6. Later Stage VC (Series B2) 01-May-2018 000.00 Completed Generating Revenue
5. Early Stage VC (Series B1) 19-Apr-2017 0000 000.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Apr-2015 000.00 000.00 000.00 Completed Startup
3. Early Stage VC 09-Sep-2013 000 000 Completed Startup
2. Accelerator/Incubator 01-Jan-2013 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ZappRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B-1 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B-2 0,000,000 00.000000
Series A 11,158,114 $0.001000 $1.3 $1.3 1x $1.3 26.79%
To view this company’s complete Cap Table, request access »

ZappRx Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CoverMyMeds Formerly PE-Backed Columbus, OH 0000 00.00 000000&0 00.00
0000000 Private Equity-Backed Rockville, MD 000 0000 000000000 0000
00000000 Venture Capital-Backed Haifa, Israel 00 000.00 000000000000 000.00
000000000 Private Equity-Backed Boston, MA 000.00 000000000000 000.00
0000000 000000 Formerly VC-backed Chicago, IL 000 0000 000000&0 0000
To view this company’s complete list of competitors, request access »

ZappRx Former Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Atlas Venture Venture Capital Minority 000 0000 000000 0
Bridge Boys Angel Group Minority 000 0000 000000 0
CureDuchenne Corporation Minority 000 0000 000000 0
David Hamamoto Angel (individual) Minority 000 0000 000000 0
EcoR1 Capital Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

ZappRx Executive Team (15)

Name Title Board
Seat
Contact
Info
Zoƫ Barry Founder & Chief Executive Officer
Sandy DiCesare Chief Operating Officer
Hans Oh Vice President, Corporate Strategy and Development
Zeeshan Khan Vice President, Product Development
Mary Hirtle Acting Chief Financial Officer

9 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

ZappRx Board Members (14)

Name Representing Role Since Contact
Info
Gary Rieschel Qiming Venture Partners Board Member 000 0000
Jeffrey Berkowitz JD Self Board Observer 000 0000
Jill Carroll SR One Board Member 000 0000
Kevin Bitterman Ph.D Atlas Venture Board Observer 000 0000
Krishna Yeshwant MD GV Board Observer 000 0000

8 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »